Search
5-(4-FLUOROPHENYL)-3-{[(4-METHYLPHENYL)SULFONYL]AMINO}THIOPHENE-2-CARBOXYLIC ACID
go.drugbank.com/drugs/DB07770ExperimentalSynonyms: 5-(4-FLUOROPHENYL)-3-{[(4-METHYLPHENYL)SULFONYL]AMINO}THIOPHENE-2-CARBOXYLIC ACIDGlatiramer
go.drugbank.com/drugs/DB05259ApprovedInvestigationalGlatiramer acetate exhibits several immunomodulatory effects and reduces the relapse rate of relapsing-remitting multiple sclerosis (RRMS) by 30%. … encephalitis (MS animal model).
Synonyms: (T,G)-A-L, COP 1Products: GLATIR® 40 MG/ML, โคแพคซอน (20 MG/ML)Mivacurium
go.drugbank.com/drugs/DB01226ApprovedWithdrawnIt binds competitively to cholinergic receptors on the motor end-plate to antagonize the action of acetylcholine, resulting in a block of neuromuscular transmission. … Mivacurium is a bisbenzylisoquinolinium based neuromuscular blocker or muscle relaxant.
Categories: Heterocyclic Compounds, 2-RingProducts: MİVACRON 20 MG/10 ML ENJEKSİYONLUK ÇÖZELTİ, 5 ADET, MIVACRON INJECTION 10 mg/5 mlRocuronium
go.drugbank.com/drugs/DB00728ApprovedInvestigational[Sugammadex] is a γ-cyclodextrin derivative that has been introduced as a novel agent to reverse the action of rocuronium. … Rocuronium (rapid onset-curonium) is a desacetoxy analogue of vecuronium with a more rapid onset of action.
Products: JECRON 50 MG/5 ML IV ENJEKSİYONLUK ÇÖZELTİ ,10 FLAKON, ANTARİN 50 MG/5 ML IV ENJEKSİYONLUK ÇÖZELTİ, 10 ADETProcaine
go.drugbank.com/drugs/DB00721ApprovedInvestigationalVet approvedA local anesthetic of the ester type that has a slow onset and a short duration of action. It is mainly used for infiltration anesthesia, peripheral nerve block, and spinal block. … (From Martindale, The Extra Pharmacopoeia, 30th ed, p1016). Procaine has also been investigated as an oral entry inhibitor in treatment-experienced HIV patients [L1215].
Synonyms: 2-Diethylaminoethyl p-aminobenzoate, 4-aminobenzoic acid 2-diethylaminoethyl esterProducts: NTCAIN 50 MG/5 ML IM AMPUL , 10 ADET, Novocain 20 mg/mlLevetiracetam
go.drugbank.com/drugs/DB01202ApprovedInvestigationalmake it a desirable choice over other AEDs, a class of drugs notorious for having generally narrow therapeutic indexes and a propensity for involvement in drug interactions. … It was first approved for use in the United States in 1999 and is structurally and mechanistically unrelated to other anti-epileptic drugs (AEDs).
Categories: Heterocyclic Compounds, 1-Ring, P-glycoprotein substratesProducts: EPILECURE 500 MG/5 ML KONSANTRE INFÜZYON ÇÖZELTISI,10 ADET, EPİXX 500 MG/5 ML KONSANTRE İNFÜZYON ÇÖZELTİSİ, 10 ADETEsmolol
go.drugbank.com/drugs/DB00187ApprovedInvestigationalWithdrawnThe FDA withdrew its approval for the use of all parenteral dosage form drug products containing esmolol hydrochloride that supply 250 milligrams/milliliter of concentrated esmolol per 10-milliliter ampule … Esmolol, commonly marketed under the trade name Brevibloc, is a cardioselective beta-1 receptor blocker.
Synonyms: Methyl 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)benzenepropanoate, (±)-methyl p-(2-hydroxy-3-(isopropylamino)propoxy)hydrocinnamateCategories: Adrenergic beta-1 Receptor Antagonists, Cytochrome P-450 Substrates5-(hexahydro-2-oxo-1H-thieno[3,4-D]imidazol-6-yl)pentanal
go.drugbank.com/drugs/DB07497ExperimentalSynonyms: 5-(hexahydro-2-oxo-1H-thieno[3,4-D]imidazol-6-yl)pentanalCTx-PDE6b
go.drugbank.com/drugs/DB17858InvestigationalCTx-PDE6b is an adeno-associated virus (AAV) based gene therapy designed to deliver a full-length non-mutated copy of the functional human _PDE6b_ gene. … Being commercialied by Coave Therapeutics, it is being investigated for the treatment of retinitis pigmentosa due to _PDE6b_ gene mutations.[L46757]
Synonyms: AAV2/5-hPDE6B